[ad_1]
According to Reuters, analysts realized an average profit of 104 million euros.
Operating profit was negatively impacted by a provision of SEK 1.8 billion to cover claims costs in North America, reported by the company on October 14.
Damage claim comes patients in North America who have been injured with surgical mesh implants manufactured by Getinge's subsidiary Atrium Medica. Getinge now sells the subsidiary.
The company's turnover, controlled by financier Carl Bennet, amounted to SEK 5,683 million, compared to SEK4,944 million a year earlier.
"We still have strong sales, but mix effects have a negative impact on our gross margin, and I'm not happy that, despite the increase in volumes, the productivity of our plants is limited. all areas of business, just as we discussed operating costs, which are now decreasing from one quarter to the next, "said Mattias Perjos, CEO of Getinge.
Read more: Getinge prepares for one billion damage
Source link
